Concert Pharmaceuticals begins THRIVE-AA2 phase 3 clinical trial for JAK inhibitors (CTP-543)
CANAAF is thrilled to share that Concert Pharmaceuticals has announced the launching of THRIVE-AA2, the second planned Phase 3 clinical
CANAAF is thrilled to share that Concert Pharmaceuticals has announced the launching of THRIVE-AA2, the second planned Phase 3 clinical
Today, we're sending a warm welcome to CANAAF's newest support group, which provides a space for people with alopecia in
International Clinical Trials Day May 20th, 2021 | #ICTD2021 May 20th is International Clinical Trials Day. Clinical trials help